Wright, George W.
National Institutes of Health · National Cancer Institute
4 papers on CoChatORCID 0000-0003-0003-0843
Most cited papers
- Verified
Genetics and pathogenesis of diffuse large B-cell lymphoma
Schmitz, R., Wright, G. W., Huang, D. W., Johnson, C. A., Phelan, J. D., Wang, J. Q., Roulland, S., Kasbekar, M., Young, R. M., Shaffer, A. L., et al. (2018) · New England Journal of Medicine
Lymphoma Diagnosis and TreatmentCNS Lymphoma Diagnosis and Treatment
Cited by 2,241
- Verified
Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple Myeloma
Annunziata, C. M., Davis, R. E., Demchenko, Y., Bellamy, W., Gabrea, A., Zhan, F., Lenz, G., Hanamura, I., Wright, G., Xiao, W., et al. (2007) · Cancer Cell
NF-κB Signaling PathwaysMultiple Myeloma Research and Treatments
Cited by 952
- Verified
IRF4 addiction in multiple myeloma
Shaffer, A. L., Emre, N. C. T., Lamy, L., Ngo, V. N., Wright, G., Xiao, W., Powell, J., Dave, S., Yu, X., Zhao, H., et al. (2008) · Nature
Multiple Myeloma Research and TreatmentsLymphoma Diagnosis and Treatment
Cited by 730
- Verified
Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma
Yang, Y., Bolomsky, A., Oellerich, T., Chen, P., Ceribelli, M., Häupl, B., Wright, G. W., Phelan, J. D., Huang, D. W., Lord, J. W., et al. (2022) · Nature Communications
PI3K/AKT/mTOR signaling in cancerMultiple Myeloma Research and Treatments
Cited by 29
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free